MedTrace Logo

Telmisartan-Induced Reduction in Intra-Myocellular Lipids Trial

NCT00147264 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2016-12-14

No results posted yet for this study

Summary

The purpose of this study is to determine whether telmisartan and/or a low-glycemic index diet are effective in reducing intra-myocellular lipid (muscle fat) content.

Conditions

  • Metabolic Syndrome X

Interventions

DRUG

Telmisartan (Micardis®) vs. Placebo

BEHAVIORAL

Low-Glycemic Index Diet vs. Control Diet

Sponsors & Collaborators

Principal Investigators

  • Arya M Sharma, MD, FRCPC · McMaster University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
FACTORIAL

Eligibility

Min Age
30 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-04-30
Primary Completion
2006-01-31
Completion
2006-11-30

Countries

  • Canada

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00147264 on ClinicalTrials.gov